Biofrontera AG Sponsored ADR Capex per Share

Capex per Share of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex per Share growth rates and interactive chart. Capex per share refers to the total amount of capital expenditures paid in a period divided by the weighted average number of shares outstanding. If a company has capex of $100 million and 10 million shares outstanding, capex per share is $10.

Highlights and Quick Summary

  • Capex per Share for the quarter ending June 30, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Capex per Share decreased by NaN%
  • Annual Capex per Share for 2021 was -0.03 (a -Infinity% decrease from previous year)
  • Annual Capex per Share for 2021 was 0.0 (a -100.0% decrease from previous year)
  • Annual Capex per Share for 2020 was -0.03 (a -Infinity% decrease from previous year)
  • Twelve month Capex per Share ending June 30, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Capex per Share decreased by NaN% year-over-year
Trailing Capex per Share for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
0.0 0.0 0.0 0.0
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex per Share of Biofrontera AG Sponsored ADR

Most recent Capex per Shareof BFAGY including historical data for past 10 years.

Interactive Chart of Capex per Share of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Capex per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – – 0.0 0.0 –
2021 0.0 0.0 -0.01 0.0 -0.03
2020 0.0 0.0 -0.02 0.0 -0.03
2019 – – 0.0 0.0 -0.09
2018 – – – -0.05 -0.03
2017 – – -0.04 -0.0 -0.02
2016 -0.03 – – – -0.03

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com